|
Men (n=471), Median (IQR)
|
Women (n=408), Median (IQR)
|
| Age, y |
46 (41–52) |
50 (44–57) |
| Total cholesterol, mmol/L |
5.15 (4.50–5.79) |
5.46 (4.73–6.08) |
| LDL cholesterol, mmol/L |
3.28 (2.66–3.85) |
3.26 (2.64–3.80) |
| HDL cholesterol, mmol/L |
1.09 (0.93–1.27) |
1.47 (1.19–1.76) |
| Triglycerides, mmol/L |
1.45 (1.03–2.05) |
1.28 (0.90–1.68) |
| Glucose, mmol/L |
5.28 (4.89–5.78) |
5.11 (4.78–5.50) |
| Insulin, pmol/L |
44.7 (29.5–67.0) |
37.9 (26.1–57.1) |
| HOMA index, units |
1.57 (0.98–2.43) |
1.32 (0.85–1.96) |
| Resistin, ng/mL |
5.20 (3.87–6.90) |
5.88 (4.42–7.84) |
| CRP, mg/dL |
1.1 (0.5–2.1) |
1.5 (0.6–3.7) |
Soluble TNF- receptor 2, µg/mL |
1.64 (1.41–1.94) |
1.69 (1.37–2.00 |
| Interleukin-6, pg/mL |
1.25 (0.80–1.92) |
1.32 (0.84–2.12) |
| Lp-PLA2, ng/mL |
315 (253–398) |
282 (224–372) |
| Soluble ICAM-1, ng/mL |
295 (260–332) |
286 (258–323) |
| Waist circumference, cm |
95.3 (88.9–104.1) |
81.3 (73.7–91.8) |
| Body mass index, kg/m2 |
27.6 (25.3–30.5) |
25.7 (22.8–30.4) |
| Systolic blood pressure |
129 (120–137) |
125 (114–136) |
| Diastolic blood pressure |
79 (74–86) |
76 (68–82) |
| Metabolic syndrome,* % |
30.4 |
23.1 |
| Smoking, % |
12.7 |
11.3 |
| Medications |
|
|
| Statins, % |
17.8 |
10.4 |
| Aspirin, % |
18.5 |
11.4 |
| Hormone replacement therapy, % |
n/a |
27.9 |
| CAC |
|
|
| CAC mean score (±SD) |
130±333 |
42±133 |
| CAC median (IQR) |
6 (1–80) |
1 (0–13) |
|
| HOMA indicates homeostasis model assessment. |
| *Metabolic syndrome as defined by the National Cholesterol Education Program. To convert values for cholesterol to mg/dL, divide by 0.0259. To convert values for triglycerides to mg/dL, divide by 0.0113. To convert values for glucose to mg/dL, divide by 0.0555. |
|